↓ Skip to main content

Recurrent respiratory papillomatosis: current and future perspectives

Overview of attention for article published in Therapeutics and Clinical Risk Management, May 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
134 Dimensions

Readers on

mendeley
166 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Recurrent respiratory papillomatosis: current and future perspectives
Published in
Therapeutics and Clinical Risk Management, May 2015
DOI 10.2147/tcrm.s81825
Pubmed ID
Authors

Marco Carifi, Domenico Napolitano, Morando Morandi, Danilo Dall’Olio

Abstract

Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive tract caused by infection with human papillomavirus, the disease process is unpredictable, ranging from mild disease and spontaneous remission to an aggressive disease with pulmonary spread and requirement for frequent surgical debulking procedures. It can present a protracted clinical course and cause potentially life-threatening compromise of the airways. Over recent decades, a number of alternative medical therapies to standard surgical treatment have been investigated, with modest outcomes overall. Currently, some additional therapies are being explored, together with novel surgical instrumentation that can help to avoid inevitable long-term stenotic complications, ultimately affecting quality of life. Hopefully, clinicians might soon be able to significantly improve the quality of treatment and outcomes for patients affected with recurrent respiratory papillomatosis, with human papillomavirus vaccination having a potentially important role.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Chile 1 <1%
Unknown 164 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 27 16%
Student > Postgraduate 22 13%
Student > Master 15 9%
Student > Doctoral Student 15 9%
Other 13 8%
Other 28 17%
Unknown 46 28%
Readers by discipline Count As %
Medicine and Dentistry 80 48%
Immunology and Microbiology 6 4%
Biochemistry, Genetics and Molecular Biology 5 3%
Engineering 5 3%
Nursing and Health Professions 4 2%
Other 13 8%
Unknown 53 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2019.
All research outputs
#7,115,687
of 25,576,275 outputs
Outputs from Therapeutics and Clinical Risk Management
#349
of 1,324 outputs
Outputs of similar age
#77,923
of 279,366 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#15
of 42 outputs
Altmetric has tracked 25,576,275 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1,324 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 279,366 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.